HughSTaylorMD
Obstetrics & Gynecology • Orange, CTReproductive Endocrinology & Infertility
Anita O'Keeffe Young Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine
Dr. Taylor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
150 Sargent Dr
Ste 2
Orange, CT 06511Phone+1 203-785-4708
Summary
- Dr. Hugh Taylor is an obstetrician/gynecologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from University of Connecticut School of Medicine and has been in practice 29 years. He specializes in reproductive endocrinology & infertility and is experienced in endometriosis, infertility, fibroids, Asherman syndrome and menopause.
He is currently Professor and Chair of Obstetrics, Gynecology and Reproductive Sciences at the Yale School of Medicine.
Education & Training
Yale-New Haven Medical CenterFellowship, Reproductive Endocrinology and Infertility, 1993 - 1996- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1988 - 1992
Uconn School Of MedicineClass of 1988
Certifications & Licensure
NY State Medical License 2020 - 2026
CT State Medical License 1991 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Awards, Honors, & Recognition
- IVI International Award
- National Academy of Medicine. 2016
- Top Doctors: New York Metro Area Castle Connolly, 2008-2014
- Join now to see all
Clinical Trials
- KEEPS Cognitive and Affective Study Start of enrollment: 2007 May 01
- Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium Start of enrollment: 2023 Nov 01
Roles: Contact, Sponsor-Investigator, Principal Investigator
- A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain Start of enrollment: 2022 Oct 25
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 111 citationsSexual function in endometriosis patients and their partners: effect of the disease and consequences of treatmentNicola Pluchino, Jean-Marie Wenger, Patrick Petignat, Reshef Tal, Mylène Bolmont
Human Reproduction Update. 2016-11-20 - 362 citationsEndometriosis is a chronic systemic disease: clinical challenges and novel innovationsHugh S. Taylor, Alexander Kotlyar, Valerie A. Flores
Lancet. 2021-02-27 - 261 citationsEffects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS–Cognitive and Affective StudyCarey E. Gleason, N. Maritza Dowling, Whitney Wharton, JoAnn E. Manson, Virginia M. Miller
Plos Medicine. 2015-06-02
Journal Articles
- "Menstruation: Science and Society" - American Journal of Obstetrics & GynecologySerdar E Bulun, Kristen A Matteson, Hugh S Taylor, American Journal of Obstetrics and Gynecology
- Progesterone Receptor Status Predicts Response to Progestin Therapy in EndometriosisValerie A Flores, Hugh S Taylor, The Journal of Clinical Endocrinology and Metabolism
Authored Content
- "Menstruation: Science and Society" - American Journal of Obstetrics & GynecologyJuly 2020
- "Menstruation: Science and Society" - American Journal of Obstetrics & GynecologyJuly 2020
Press Mentions
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy DesignationOctober 24th, 2024- Stem Cell Research Reveals New Clues to Tissue Repair That Could Help Heal the Uterus and MoreMay 30th, 2024
- Connecticut Magazine’s 2023 “Top Doctors” Issue Recognizes 82 Smilow Cancer Hospital and Yale Cancer Center PhysiciansMay 1st, 2023
- Join now to see all
Grant Support
- Project 1Eunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- Alteration Of HOX Gene Expression By Endocrine Disrupting ChemicalsNational Institute Of Environmental Health Sciences2007–2011
- Contribution Of Adult Bone Marrow-Derived Stem Cells To EndometriumEunice Kennedy Shriver National Institute Of Child Health &Human Development2007–2011
- Center For Endometrial Biology And EndometriosisEunice Kennedy Shriver National Institute Of Child Health &Human Development2007–2011
- Administrtive CellsEunice Kennedy Shriver National Institute Of Child Health &Human Development2007
- HOX Gene Expression In Human EndometriumEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2007
- HOX Gene Expression By Endocrine Disrupting ChemicalsNational Institute Of Environmental Health Sciences2001–2005
- HOX Gene Expression In Human EndometriumEunice Kennedy Shriver National Institute Of Child Health &Human Development1998–2002
- Determination Of Homeobox Gene SpecificityEunice Kennedy Shriver National Institute Of Child Health &Human Development1993–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
